| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Heron Therapeutics Inc (NASDAQ: HRTX)
HRTX Technical Analysis
5
| As on 9th Jun 2023 HRTX STOCK Price closed @ 1.24 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.04 & Strong Sell for SHORT-TERM with Stoploss of 8.35 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HRTXSTOCK Price
| Open | 1.20 | Change | Price | % |
| High | 1.32 | 1 Day | 0.05 | 4.20 |
| Low | 1.20 | 1 Week | 0.05 | 4.20 |
| Close | 1.24 | 1 Month | -1.28 | -50.79 |
| Volume | 3172354 | 1 Year | -8.54 | -87.32 |
| 52 Week High 10.24 | 52 Week Low 1.11 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| HRTX Daily Charts |
HRTX Intraday Charts |
Whats New @ Bazaartrend |
HRTX Free Analysis |
|
|
HRTX Important Levels Intraday
| RESISTANCE | 1.47 |
| RESISTANCE | 1.40 |
| RESISTANCE | 1.35 |
| RESISTANCE | 1.31 |
| SUPPORT | 1.17 |
| SUPPORT | 1.13 |
| SUPPORT | 1.08 |
| SUPPORT | 1.01 |
HRTX Forecast May 2024
| 4th UP Forecast | 4.44 |
| 3rd UP Forecast | 3.41 |
| 2nd UP Forecast | 2.78 |
| 1st UP Forecast | 2.14 |
| 1st DOWN Forecast | 0.34 |
| 2nd DOWN Forecast | -0.3 |
| 3rd DOWN Forecast | -0.93 |
| 4th DOWN Forecast | -1.96 |
HRTX Weekly Forecast
| 4th UP Forecast | 4.50 |
| 3rd UP Forecast | 3.45 |
| 2nd UP Forecast | 2.81 |
| 1st UP Forecast | 2.16 |
| 1st DOWN Forecast | 0.32 |
| 2nd DOWN Forecast | -0.33 |
| 3rd DOWN Forecast | -0.97 |
| 4th DOWN Forecast | -2.02 |
HRTX Forecast2024
| 4th UP Forecast | 19.33 |
| 3rd UP Forecast | 13.53 |
| 2nd UP Forecast | 9.94 |
| 1st UP Forecast | 6.36 |
| 1st DOWN Forecast | -3.88 |
| 2nd DOWN Forecast | -7.46 |
| 3rd DOWN Forecast | -11.05 |
| 4th DOWN Forecast | -16.85 |
Heron Therapeutics Inc ( NASDAQ USA Symbol : HRTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HRTX Business Profile
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing HTX-011, an investigational, dual-acting, and fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam, which is in Phase III clinical trials for pain management; and HTX-034, which is in Phase Ib/II clinical trials for postoperative pain management. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California. Address: 4242 Campus Point Court, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service